Masimo Corporation MASI NASDAQ

Masimo Corporation (MASI) reported total assets of $1.7B and total liabilities of $977.7M for fiscal year 2025, resulting in total equity of $721.2M.

The company held $152.3M in cash and short-term investments. Total debt stood at $559.3M, with net debt of $407M. The Debt-to-Equity (D/E) ratio was 0.78 (moderate).

Current ratio is 2.49, indicating strong short-term liquidity. Interest coverage is 9.4x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.78, current ratio of 2.49, interest coverage 9.4x — balance sheet is strong
• MOAT (74/100) — Total assets $1.7B and equity $721.2M support the company's competitive scale
• VALUE (60/100) — Debt-to-Equity 0.78 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 50/100 with 4/7 criteria passed.

DXCM

DexCom, Inc.

$62.95

-0.27%

PODD

Insulet Corporation

$201.49

+1.86%

PEN

Penumbra, Inc.

$332.17

+0.21%

SWAV

ShockWave Medical, Inc.

$334.75

-0.02%

GKOS

Glaukos Corporation

$120.52

+0.86%

NARI

Inari Medical, Inc.

$79.97

+0.00%

TMDX

TransMedics Group, Inc.

$115.68

+2.05%

LIVN

LivaNova PLC

$64.99

+0.63%